Johnson & Johnson - stock earnings
JNJ Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 17, 2024 BeforeMarket | - / - | 21.9 billion | - / 22.3 billion | 22.6 billion |
JNJ Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 5.4 billion USD | 21.4 billion USD |
| 2023Q4 | 4.0 billion USD | 21.4 billion USD |
| 2023Q3 | 26.0 billion USD | 21.3 billion USD |
| 2023Q2 | 5.1 billion USD | 25.5 billion USD |
| 2023Q1 | -68.0 million USD | 24.7 billion USD |
| 2022Q4 | 3.5 billion USD | 23.7 billion USD |
| 2022Q3 | 4.5 billion USD | 23.8 billion USD |
| 2022Q2 | 4.8 billion USD | 24.0 billion USD |
| 2022Q1 | 5.1 billion USD | 23.4 billion USD |
| 2021Q4 | 4.7 billion USD | 24.8 billion USD |
| 2021Q3 | 3.7 billion USD | 23.3 billion USD |
| 2021Q2 | 6.3 billion USD | 23.3 billion USD |
| 2021Q1 | 6.2 billion USD | 22.3 billion USD |
| 2020Q4 | 1.7 billion USD | 22.5 billion USD |
| 2020Q3 | 3.6 billion USD | 21.1 billion USD |
| 2020Q2 | 3.6 billion USD | 18.3 billion USD |
| 2020Q1 | 5.8 billion USD | 20.7 billion USD |
| 2019Q4 | 4.0 billion USD | 20.7 billion USD |
| 2019Q3 | 4.8 billion USD | 20.7 billion USD |
| 2019Q2 | 5.6 billion USD | 20.6 billion USD |
| 2019Q1 | 3.7 billion USD | 20.0 billion USD |
| 2018Q4 | 3.0 billion USD | 20.4 billion USD |
| 2018Q3 | 3.9 billion USD | 20.3 billion USD |
| 2018Q2 | 4.0 billion USD | 20.8 billion USD |
| 2018Q1 | 4.4 billion USD | 20.0 billion USD |
| 2017Q4 | -10.7 billion USD | 20.2 billion USD |
| 2017Q3 | 3.8 billion USD | 19.7 billion USD |
| 2017Q2 | 3.8 billion USD | 18.8 billion USD |
| 2017Q1 | 4.4 billion USD | 17.8 billion USD |
| 2016Q4 | 3.8 billion USD | 18.1 billion USD |
| 2016Q3 | 4.3 billion USD | 17.8 billion USD |
| 2016Q2 | 4.0 billion USD | 18.5 billion USD |
| 2016Q1 | 4.3 billion USD | 17.5 billion USD |
| 2015Q4 | 3.2 billion USD | 17.8 billion USD |
| 2015Q3 | 3.4 billion USD | 17.1 billion USD |
| 2015Q2 | 4.5 billion USD | 17.8 billion USD |
| 2015Q1 | 4.3 billion USD | 17.4 billion USD |
| 2014Q4 | 2.5 billion USD | 18.3 billion USD |
| 2014Q3 | 4.7 billion USD | 18.5 billion USD |
| 2014Q2 | 4.3 billion USD | 19.5 billion USD |
| 2014Q1 | 4.7 billion USD | 18.1 billion USD |
| 2013Q4 | 3.5 billion USD | 18.4 billion USD |
| 2013Q3 | 3.0 billion USD | 17.6 billion USD |
| 2013Q2 | 3.8 billion USD | 17.9 billion USD |
| 2013Q1 | 3.5 billion USD | 17.5 billion USD |
| 2012Q4 | 2.6 billion USD | 17.6 billion USD |
| 2012Q3 | 3.0 billion USD | 17.1 billion USD |
| 2012Q2 | 1.4 billion USD | 16.5 billion USD |
| 2012Q1 | 3.9 billion USD | 16.1 billion USD |
| 2011Q4 | 218.0 million USD | 16.3 billion USD |
| 2011Q3 | 3.2 billion USD | 16.0 billion USD |
| 2011Q2 | 2.8 billion USD | 16.6 billion USD |
| 2011Q1 | 3.5 billion USD | 16.2 billion USD |
| 2010Q4 | 1.9 billion USD | 15.6 billion USD |
| 2010Q3 | 3.4 billion USD | 15.0 billion USD |
| 2010Q2 | 3.4 billion USD | 15.3 billion USD |
| 2010Q1 | 4.5 billion USD | 15.6 billion USD |
| 2009Q4 | 2.2 billion USD | 16.6 billion USD |
| 2009Q3 | 3.3 billion USD | 15.1 billion USD |
| 2009Q2 | 3.2 billion USD | 15.2 billion USD |
| 2009Q1 | 3.5 billion USD | 15.0 billion USD |
| 2008Q4 | 2.7 billion USD | 15.2 billion USD |
| 2008Q3 | 3.3 billion USD | 15.9 billion USD |
| 2008Q2 | 3.3 billion USD | 16.5 billion USD |
| 2008Q1 | 3.6 billion USD | 16.2 billion USD |
| 2007Q4 | 2.4 billion USD | 16.0 billion USD |
| 2007Q3 | 2.5 billion USD | 15.0 billion USD |
| 2007Q2 | 3.1 billion USD | 15.1 billion USD |
| 2007Q1 | 2.6 billion USD | 15.0 billion USD |
| 2006Q4 | 2.2 billion USD | 13.7 billion USD |
| 2006Q3 | 2.8 billion USD | 13.3 billion USD |
| 2006Q2 | 2.8 billion USD | 13.4 billion USD |
| 2006Q1 | 3.3 billion USD | 13.0 billion USD |
| 2005Q4 | 2.2 billion USD | 12.6 billion USD |
| 2005Q3 | 2.6 billion USD | 12.3 billion USD |
| 2005Q2 | 2.7 billion USD | 12.8 billion USD |
| 2005Q1 | 2.9 billion USD | 12.8 billion USD |
| 2004Q4 | 1.2 billion USD | 12.8 billion USD |
| 2004Q3 | 2.3 billion USD | 11.6 billion USD |
| 2004Q2 | 2.5 billion USD | 11.5 billion USD |
| 2004Q1 | 2.5 billion USD | 11.6 billion USD |
| 2003Q4 | 1.8 billion USD | 11.3 billion USD |
| 2003Q3 | 2.1 billion USD | 10.5 billion USD |
| 2003Q2 | 1.2 billion USD | 10.3 billion USD |
| 2003Q1 | 2.1 billion USD | 9.8 billion USD |
| 2002Q4 | 1.4 billion USD | 9.4 billion USD |
| 2002Q3 | 1.7 billion USD | 9.1 billion USD |
| 2002Q2 | 1.7 billion USD | 9.1 billion USD |
| 2002Q1 | 1.8 billion USD | 8.7 billion USD |
| 2001Q4 | 1.1 billion USD | 8.4 billion USD |
| 2001Q3 | 1.5 billion USD | 8.2 billion USD |
| 2001Q2 | 1.5 billion USD | 8.3 billion USD |
| 2001Q1 | 1.5 billion USD | 7.8 billion USD |
| 2000Q4 | 891.0 million USD | 7.1 billion USD |
| 2000Q3 | 1.3 billion USD | 7.2 billion USD |
| 2000Q2 | 1.3 billion USD | 7.5 billion USD |
| 2000Q1 | 1.3 billion USD | 7.3 billion USD |
| 1999Q4 | 785.0 million USD | 7.2 billion USD |
| 1999Q3 | 1.1 billion USD | 6.7 billion USD |
| 1999Q2 | 1.2 billion USD | 6.9 billion USD |
| 1999Q1 | 83.0 million USD | 6.4 billion USD |
| 1998Q4 | 49.0 million USD | 6.9 billion USD |
| 1998Q3 | 961.0 million USD | 5.7 billion USD |
| 1998Q2 | 1.0 billion USD | 5.8 billion USD |
| 1998Q1 | 1.0 billion USD | 5.8 billion USD |
| 1997Q4 | 630.0 million USD | 5.6 billion USD |
| 1997Q3 | 855.0 million USD | 5.6 billion USD |
| 1997Q2 | 909.0 million USD | 5.7 billion USD |
| 1997Q1 | 909.0 million USD | 5.7 billion USD |
| 1996Q4 | 556.0 million USD | 5.5 billion USD |
| 1996Q3 | 750.0 million USD | 5.4 billion USD |
| 1996Q2 | 791.0 million USD | 5.4 billion USD |
| 1996Q1 | 465.0 million USD | 4.8 billion USD |
| 1995Q4 | 465.0 million USD | 4.8 billion USD |
| 1995Q3 | 623.0 million USD | 4.7 billion USD |
| 1995Q2 | 661.0 million USD | 4.8 billion USD |
| 1995Q1 | 378.0 million USD | 4.1 billion USD |
| 1994Q4 | 378.0 million USD | 4.1 billion USD |
| 1994Q3 | 525.0 million USD | 4.0 billion USD |
| 1994Q2 | 495.0 million USD | 3.5 billion USD |
| 1994Q1 | 335.0 million USD | 3.5 billion USD |
| 1993Q4 | 335.0 million USD | 3.5 billion USD |
| 1993Q3 | 454.0 million USD | 3.5 billion USD |
| 1993Q2 | 495.0 million USD | 3.5 billion USD |
| 1993Q1 | 503.0 million USD | 3.6 billion USD |
| 1992Q4 | -323.0 million USD | 3.5 billion USD |
| 1992Q3 | 425.0 million USD | 3.5 billion USD |
| 1992Q2 | 464.0 million USD | 3.4 billion USD |
| 1992Q1 | 464.0 million USD | 3.4 billion USD |
| 1991Q4 | 274.0 million USD | 3.1 billion USD |
| 1991Q3 | 363.0 million USD | 3.1 billion USD |
| 1991Q2 | 406.0 million USD | 3.0 billion USD |
| 1991Q1 | 418.0 million USD | 3.1 billion USD |
| 1990Q4 | 232.0 million USD | 2.7 billion USD |
| 1990Q3 | 314.0 million USD | 2.9 billion USD |
| 1990Q2 | 353.0 million USD | 2.8 billion USD |
| 1990Q1 | 244.0 million USD | 2.8 billion USD |
| 1989Q4 | 203.0 million USD | 2.5 billion USD |
| 1989Q3 | 265.0 million USD | 2.5 billion USD |
| 1989Q2 | ? USD | 2.4 billion USD |
| 1989Q1 | 317.0 million USD | 2.4 billion USD |
| 1988Q4 | ? USD | 2.2 billion USD |
| 1988Q3 | ? USD | 2.2 billion USD |
| 1988Q2 | ? USD | 2.3 billion USD |
| 1988Q1 | ? USD | 2.3 billion USD |
| 1987Q4 | ? USD | 2.0 billion USD |
| 1987Q3 | ? USD | 2.0 billion USD |
| 1987Q2 | ? USD | 2.0 billion USD |
| 1987Q1 | ? USD | 2.0 billion USD |
| 1986Q4 | ? USD | 1.7 billion USD |
| 1986Q3 | ? USD | 1.8 billion USD |
| 1986Q2 | ? USD | 1.7 billion USD |
| 1986Q1 | ? USD | 1.7 billion USD |
| 1985Q4 | ? USD | 1.7 billion USD |
| 1985Q3 | ? USD | 1.6 billion USD |
JNJ Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 35.2 billion USD | 85.2 billion USD |
| 2022 | 17.9 billion USD | 94.9 billion USD |
| 2021 | 20.9 billion USD | 93.8 billion USD |
| 2020 | 14.7 billion USD | 82.6 billion USD |
| 2019 | 15.1 billion USD | 82.1 billion USD |
| 2018 | 15.3 billion USD | 81.6 billion USD |
| 2017 | 1.3 billion USD | 76.5 billion USD |
| 2016 | 16.5 billion USD | 71.9 billion USD |
| 2015 | 15.4 billion USD | 70.1 billion USD |
| 2014 | 16.3 billion USD | 74.3 billion USD |
| 2013 | 13.8 billion USD | 71.3 billion USD |
| 2012 | 10.9 billion USD | 67.2 billion USD |
| 2011 | 9.7 billion USD | 65.0 billion USD |
| 2010 | 13.3 billion USD | 61.6 billion USD |
| 2009 | 12.3 billion USD | 61.9 billion USD |
| 2008 | 12.9 billion USD | 63.7 billion USD |
| 2007 | 10.6 billion USD | 61.1 billion USD |
| 2006 | 11.1 billion USD | 53.3 billion USD |
| 2005 | 10.4 billion USD | 50.5 billion USD |
| 2004 | 8.5 billion USD | 47.3 billion USD |
| 2003 | 7.2 billion USD | 41.9 billion USD |
| 2002 | 6.6 billion USD | 36.3 billion USD |
| 2001 | 5.7 billion USD | 33.0 billion USD |
| 2000 | 4.8 billion USD | 29.1 billion USD |
| 1999 | 4.2 billion USD | 27.5 billion USD |
| 1998 | 3.1 billion USD | 23.7 billion USD |
| 1997 | 3.3 billion USD | 22.6 billion USD |
| 1996 | 2.9 billion USD | 21.6 billion USD |
| 1995 | 2.4 billion USD | 18.8 billion USD |
| 1994 | 2.0 billion USD | 15.7 billion USD |
| 1993 | 1.8 billion USD | 14.1 billion USD |
| 1992 | 1.0 billion USD | 13.8 billion USD |
| 1991 | 1.5 billion USD | 12.4 billion USD |
| 1990 | 1.1 billion USD | 11.2 billion USD |
| 1989 | 1.1 billion USD | 9.8 billion USD |
| 1988 | 974.0 million USD | 9.0 billion USD |
| 1987 | 833.0 million USD | 8.0 billion USD |
| 1986 | 329.5 million USD | 7.0 billion USD |
| 1985 | 613.7 million USD | 6.4 billion USD |
JNJ
List: Champions
Price: $146.82
52 week price:
Dividend Yield: 3.35%
5-year range yield:
Forward Dividend Yield: 3.34%
Payout Ratio: 91.54%
Payout Ratio Range:
Dividend Per Share: 4.96 USD
Earnings Per Share: 5.21 USD
P/E Ratio: 30.40
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 356.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 63
DGR3: 5.62%
DGR5: 5.76%
DGR10: 5.98%
DGR20: 8.12%